Amrize (NYSE:AMRZ) CTO Roald Brouwer Acquires 2,000 Shares

Amrize Ltd (NYSE:AMRZ) CTO Roald Brouwer acquired 2,000 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were purchased at an average price of $54.88 per share, with a total value of $109,760.00. Following the completion of the transaction, the chief technology officer owned 18,257 shares of the company’s stock, valued at $1,001,944.16. The trade was a 12.30% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Roald Brouwer also recently made the following trade(s):

• On Wednesday, March 11th, Roald Brouwer bought 3,000 shares of Amrize stock. The stock was purchased at an average price of $58.72 per share, for a total transaction of $176,160.00.

Amrize Stock Performance

NYSE:AMRZ opened at $56.42 on Tuesday. The company’s 50-day moving average is $57.93 and its two-hundred day moving average is $53.73. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. The firm has a market capitalization of $31.20 billion and a price-to-earnings ratio of 22.93.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The business’s quarterly revenue was down .4% on a year-over-year basis.

Analyst Ratings Changes

A number of equities research analysts have commented on AMRZ shares. Oppenheimer restated an “outperform” rating and issued a $70.00 target price (up from $64.00) on shares of Amrize in a research report on Thursday, February 19th. Vertical Research started coverage on Amrize in a report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price target for the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. Bank of America set a $58.00 price objective on shares of Amrize in a report on Monday, January 12th. Finally, JPMorgan Chase & Co. upped their target price on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Thursday, March 5th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $64.14.

Hedge Funds Weigh In On Amrize

Several hedge funds have recently bought and sold shares of the company. MCF Advisors LLC acquired a new position in Amrize in the 4th quarter valued at about $27,000. State of Wyoming acquired a new stake in shares of Amrize during the third quarter worth about $32,000. Basepoint Wealth LLC purchased a new position in shares of Amrize in the fourth quarter valued at approximately $33,000. Laurel Wealth Advisors LLC purchased a new position in shares of Amrize in the fourth quarter valued at approximately $34,000. Finally, US Bancorp DE acquired a new position in shares of Amrize in the third quarter valued at approximately $38,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.